Cargando…
Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes
[Image: see text] Cancer is among the main causes of mortality all over the world. The delayed diagnosis is directly related to the decrease in survival rate. The use of immunotherapy has dramatically changed the treatment outcomes of different types of cancers. However, many patients still do not r...
Autores principales: | Nasser, Tasneem A., Adel, Rawan, Badr, Abdelrahman, Teleb, Mohamed, Bekhit, Adnan A., Elkhodairy, Kadria A., Abdelhamid, Ahmed S., Elzoghby, Ahmed O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909687/ https://www.ncbi.nlm.nih.gov/pubmed/36777563 http://dx.doi.org/10.1021/acsomega.2c05986 |
Ejemplares similares
-
Engineered Sericin-Tagged
Layered Double Hydroxides
for Combined Delivery of Pemetrexed and ZnO Quantum Dots as Biocompatible
Cancer Nanotheranostics
por: Abdelgalil, Riham M., et al.
Publicado: (2023) -
Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy
por: Mokhtar, Sarah, et al.
Publicado: (2022) -
Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment
por: Salah, Mai, et al.
Publicado: (2022) -
Critical reviews of immunotheranostics
por: Chen, Xiaoyuan, et al.
Publicado: (2020) -
Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand
por: Elzoghby, Ahmed O., et al.
Publicado: (2020)